Manuela Fuchs

Manuela Fuchs

Auto-generated profile, based on publicly available information

Manuela Fuchs

Helmholtz Centre for Infection Research (HZI), Helmholtz Institute for RNA-based Infection Research (HIRI) , 97080 Würzburg , Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MFManuela Fuchs
Manuela Fuchs
VLVanessa Lamm-Schmidt
Vanessa Lamm-Schmidt
JSJohannes Sulzer
Johannes Sulzer
FPFalk Ponath
Falk Ponath
LJLaura Jenniches
Laura Jenniches
FFFranziska Faber
Franziska Faber
Significance: Clostridioides difficile is the leading cause of healthcare-associated diarrhea worldwide following antibiotic treatment. Consequently, there is medical need for novel antibacterial agents acting against C. difficile that leave the resident microbiota unharmed. The development of such narrow-spectrum antibiotics requires precise knowledge of the mechanisms that fine-tune gene expression to orchestrate the genomic output at each locus in the genome. We address this issue by defining the global transcriptome architecture of C. difficile including noncoding regulatory elements, many of which are expressed during gut colonization. Our analysis of these regulators provides evidence for the global function of Hfq in sRNA binding and stabilization in a gram-positive bacterium.

22 April 2021 in microLife
Verified
Journal Article
Open access
PDF file
VLVanessa Lamm-Schmidt
Vanessa Lamm-Schmidt
MFManuela Fuchs
Manuela Fuchs
JSJohannes Sulzer
Johannes Sulzer
MGMilan Gerovac
Milan Gerovac
JHJens Hör
Jens Hör
FFFranziska Faber
Franziska Faber
Much of our current knowledge about cellular RNA–protein complexes in bacteria is derived from analyses in gram-negative model organisms, with the discovery of RNA-binding proteins (RBPs) generally lagging behind in Gram-positive species. Here, we have applied Grad-seq analysis of native RNA–protein complexes to a major Gram-positive human pathogen, Clostridioides difficile, whose RNA biology remains largely unexplored. Our analysis resolves in-gradient distributions for ∼88% of all annotated transcripts and ∼50% of all proteins, thereby providing a comprehensive resource for the discovery of RNA–protein and protein–protein complexes in C. difficile and related microbes. The sedimentation profiles together with pulldown approaches identify KhpB, previously identified in Streptococcus pneumoniae, as an uncharacterized, pervasive RBP in C. difficile. Global RIP-seq analysis establishes a large suite of mRNA and small RNA targets of KhpB, similar to the scope of the Hfq targetome in C. difficile. The KhpB-bound transcripts include several functionally related mRNAs encoding virulence-associated metabolic pathways and toxin A whose transcript levels are observed to be increased in a khpB deletion strain. Moreover, the production of toxin protein is also increased upon khpB deletion. In summary, this study expands our knowledge of cellular RNA protein interactions in C. difficile and supports the emerging view that KhpB homologues constitute a new class of globally acting RBPs in Gram-positive bacteria.

4 May 2023 in The EMBO Journal
Verified
Journal Article
Open access
MFManuela Fuchs
Manuela Fuchs
VLVanessa Lamm‐Schmidt
Vanessa Lamm‐Schmidt
TLTina Lenče
Tina Lenče
JSJohannes Sulzer
Johannes Sulzer
ABArne Bublitz
Arne Bublitz
FFFranziska Faber
Franziska Faber
The obligate anaerobic, enteric pathogen Clostridioides difficile persists in the intestinal tract by forming antibiotic‐resistant endospores that contribute to relapsing and recurrent infections. Despite the importance of sporulation for C. difficile pathogenesis, environmental cues and molecular mechanisms that regulate sporulation initiation remain ill‐defined. Here, by using RIL‐seq to globally capture the Hfq‐dependent RNA–RNA interactome, we discovered a network of small RNAs that bind to mRNAs encoding sporulation‐related genes. We show that two of these small RNAs, SpoX and SpoY, regulate translation of the master regulator of sporulation, Spo0A, in an opposing manner, which ultimately leads to altered sporulation rates. Infection of antibiotic‐treated mice with SpoX and SpoY deletion mutants revealed a global effect on gut colonization and intestinal sporulation. Our work uncovers an elaborate RNA–RNA interactome controlling the physiology and virulence of C. difficile and identifies a complex post‐transcriptional layer in the regulation of spore formation in this important human pathogen.

25 June 2024 in PNAS Nexus
Verified
Journal Article
Open access
PDF file
CBChristian Behlendorf
Christian Behlendorf
MDMaurice Diwo
Maurice Diwo
MNMeina Neumann-Schaal
Meina Neumann-Schaal
MFManuela Fuchs
Manuela Fuchs
DKDominik Körner
Dominik Körner
WBWulf Blankenfeldt
Wulf Blankenfeldt
Stickland fermentation, the coupled oxidation and reduction of amino acid pairs, is a major pathway for obtaining energy in the nosocomial bacterium Clostridioides difficile. D-proline is the preferred substrate for the reductive path, making it not only a key component of the general metabolism but also impacting on the expression of the clostridial toxins TcdA and TcdB. D-proline reduction is catalyzed by the proline reductase Prd, which belongs to the pyruvoyl-dependent enzymes. These enzymes are translated as inactive proenzymes and require subsequent processing to install the covalently bound pyruvate. Whereas pyruvoyl formation by intramolecular serinolysis has been studied in unrelated enzymes, details about pyruvoyl generation by cysteinolysis as in Prd are lacking. Here, we show that Prd maturation requires a small dimeric protein that we have named PrdH. PrdH (CD630_32430) is co-encoded with the PrdA and PrdB subunits of Prd and also found in species producing similar reductases. By producing stable variants of PrdA and PrdB, we demonstrate that PrdH-mediated cleavage and pyruvoyl formation in the PrdA subunit requires PrdB, which can be harnessed to produce active recombinant Prd for subsequent analyses. We further created PrdA- and PrdH-mutants to get insight into the interaction of the components and into the processing reaction itself. Finally, we show that deletion of prdH renders C. difficile insensitive to proline concentrations in culture media, suggesting that this processing factor is essential for proline utilization. Due to the link between Stickland fermentation and pathogenesis, we suggest PrdH may be an attractive target for drug development.

17 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MFManuela Fuchs
Manuela Fuchs
VLVanessa Lamm-Schmidt
Vanessa Lamm-Schmidt
TLTina Lenče
Tina Lenče
JSJohannes Sulzer
Johannes Sulzer
ABArne Bublitz
Arne Bublitz
FFFranziska Faber
Franziska Faber
The obligate anaerobic, enteric pathogen Clostridioides difficile persists in the intestinal tract by forming antibiotic resistant endospores that contribute to relapsing and recurrent infections. Despite the importance of sporulation for C. difficile pathogenesis, environmental cues, and molecular mechanisms regulating sporulation initiation remain ill defined. Here, using RIL-seq to capture the Hfq-dependent RNA-RNA interactome, we discovered a network of small RNAs that bind to mRNAs encoding sporulation-related genes. We show that two of these small RNAs, SpoX and SpoY, regulate translation of the master regulator of sporulation, Spo0A, in an opposing manner, which ultimately leads to altered sporulation rates. Infection of antibiotic-treated mice with SpoX and SpoY deletion mutants revealed a global effect on gut colonization and intestinal sporulation. Our work uncovers an elaborate RNA-RNA interactome controlling the physiology and virulence of C. difficile and identifies a complex post-transcriptional layer in the regulation of spore formation in this important human pathogen.

20 December 2025 in bioRxiv
Verified
Preprint
Open access
NKNatalie Kyte
Natalie Kyte
MFManuela Fuchs
Manuela Fuchs
LSLeah M Smith
Leah M Smith
PFPeter Fineran
Peter Fineran
Phages are important drivers of bacterial evolution with therapeutic potential as antimicrobials. However, gaps in our understanding of phages and our inability to rapidly engineer them with new genetic cargo hinders progress towards phage-based therapies. To address the lack of unbiased, genome-wide mutational tools for phages, we developed transposon mutagenesis employing CRISPR-anti-CRISPR (Acr)-based selection and deep-sequencing (Phage Tn-seq). Transposon mutagenesis was effective for phages with unmodified or hypermodified genomes and a jumbo phage that protects its DNA within a nucleus. Phage Tn-seq enabled phage gene essentiality assignment consistent with structural proteomics and core gene conservation. Insertion biases allowed prediction of transcriptional direction and early injected phage DNA regions. We exploited the method to rapidly deliver new cargo to phage genomes in just a few days and used an AI-designed Acr to expand the phage transposon toolbox. Phage Tn-seq is a versatile tool to advance our understanding and applications of phages.